MAPK1 and head and neck squamous cell carcinoma: In conclusion, a pleiotropic oncogenic role for TROP2 has been identified in HNSCC, in which its over-expression promotes tumor progression and associates with patient survival by regulating AKT and ERK/MAPK signaling pathways.